Ryan Specialty (RYAN) swings to Q1 2026 profit as revenue climbs
Ryan Specialty Holdings reported solid growth for the quarter ended March 31, 2026. Total revenue rose to $795.2 million, driven mainly by net commissions and fees of $782.9 million, up from $676.1 million a year earlier. Net income was $40.6 million, compared with a net loss of $4.4 million in the prior-year quarter, and diluted earnings per Class A share improved to $0.13 from a loss of $0.22.
The company remains highly leveraged, with total debt of about $3.57 billion and significant use of its $1.4 billion revolving credit facility. It launched the Empower restructuring program, expecting total costs of $160 million through 2028 and projected annual savings of about $80 million in 2029. During the quarter, Ryan Specialty repurchased 982,073 Class A shares for roughly $40 million and paid a regular quarterly cash dividend of $0.13 per Class A share.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Empower program financial
Term Loan financial
Revolving Credit Facility financial
Tax Receivable Agreement financial
non-controlling interests financial
Variable interest entity (VIE) financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
How did Ryan Specialty (RYAN) perform in the quarter ended March 31, 2026?
What were Ryan Specialty’s key revenue drivers in Q1 2026?
What earnings per share did Ryan Specialty (RYAN) report for Q1 2026?
How leveraged is Ryan Specialty based on its March 31, 2026 balance sheet?
What is Ryan Specialty’s Empower restructuring program?
Did Ryan Specialty (RYAN) return capital to shareholders in Q1 2026?
How much non-controlling interest does Ryan Specialty have in its main operating LLC?

(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) | |||
(Address of principal executive offices) | (Zip Code) |
( |
(Registrant’s telephone number, including area code) |
Title of each class | Trading symbol | Name of each exchange on which registered | ||
☒ | Accelerated filer | ☐ | ||
Non-accelerated filer | ☐ | Smaller reporting company | ||
Emerging growth company |
PART I. FINANCIAL INFORMATION | 1 | |
Item 1. | Financial Statements | 1 |
Consolidated Statements of Income (Loss) (Unaudited) | 1 | |
Consolidated Statements of Comprehensive Income (Loss) (Unaudited) | 2 | |
Consolidated Balance Sheets (Unaudited) | 3 | |
Consolidated Statements of Cash Flows (Unaudited) | 4 | |
Consolidated Statements of Stockholders’ Equity (Unaudited) | 5 | |
Notes to the Consolidated Financial Statements (Unaudited) | 6 | |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 28 |
Item 3. | Quantitative and Qualitative Disclosure About Market Risk | 47 |
Item 4. | Controls and Procedures | 48 |
PART II. OTHER INFORMATION | 48 | |
Item 1. | Legal Proceedings | 49 |
Item 1A. | Risk Factors | 49 |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 49 |
Item 3. | Defaults Upon Senior Securities | 49 |
Item 4. | Mine Safety Disclosures | 49 |
Item 5. | Other Information | 49 |
Item 6. | Exhibits | 51 |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
REVENUE | ||||
Net commissions and fees | $ | $ | ||
Fiduciary investment income | ||||
Total revenue | $ | $ | ||
EXPENSES | ||||
Compensation and benefits | ||||
General and administrative | ||||
Amortization | ||||
Depreciation | ||||
Change in contingent consideration | ( | |||
Total operating expenses | $ | $ | ||
OPERATING INCOME | $ | $ | ||
Interest expense, net | ||||
Income from equity method investments | ( | ( | ||
Other non-operating income | ( | ( | ||
INCOME BEFORE INCOME TAXES | $ | $ | ||
Income tax expense | ||||
NET INCOME (LOSS) | $ | $( | ||
Net income attributable to non-controlling interests, net of tax | ||||
NET INCOME (LOSS) ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $( | ||
NET INCOME (LOSS) PER SHARE OF CLASS A COMMON STOCK: | ||||
Basic | $ | $( | ||
Diluted | $ | $( | ||
WEIGHTED-AVERAGE SHARES OF CLASS A COMMON STOCK OUTSTANDING: | ||||
Basic | ||||
Diluted | ||||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
NET INCOME (LOSS) | $ | $( | ||
Net income attributable to non-controlling interests, net of tax | ||||
NET INCOME (LOSS) ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $( | ||
Other comprehensive income (loss), net of tax: | ||||
Gain on interest rate cap | ||||
Gain on interest rate cap reclassified to earnings | ( | |||
Foreign currency translation adjustments | ( | |||
Change in share of equity method investments’ other comprehensive income (loss) | ( | |||
Total other comprehensive income (loss), net of tax | $( | $ | ||
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $( | ||
March 31, 2026 | December 31, 2025 | |||
ASSETS | ||||
CURRENT ASSETS | ||||
Cash and cash equivalents | $ | $ | ||
Commissions and fees receivable – net | ||||
Fiduciary cash and receivables | ||||
Prepaid incentives – net | ||||
Other current assets | ||||
Total current assets | $ | $ | ||
NON-CURRENT ASSETS | ||||
Goodwill | ||||
Customer relationships | ||||
Other intangible assets | ||||
Prepaid incentives – net | ||||
Equity method investments | ||||
Property and equipment – net | ||||
Lease right-of-use assets | ||||
Deferred tax assets | ||||
Other non-current assets | ||||
Total non-current assets | $ | $ | ||
TOTAL ASSETS | $ | $ | ||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
CURRENT LIABILITIES | ||||
Accounts payable and accrued liabilities | $ | $ | ||
Accrued compensation | ||||
Operating lease liabilities | ||||
Tax Receivable Agreement liabilities | ||||
Short-term debt and current portion of long-term debt | ||||
Fiduciary liabilities | ||||
Total current liabilities | $ | $ | ||
NON-CURRENT LIABILITIES | ||||
Accrued compensation | ||||
Operating lease liabilities | ||||
Long-term debt | ||||
Tax Receivable Agreement liabilities | ||||
Deferred tax liabilities | ||||
Other non-current liabilities | ||||
Total non-current liabilities | $ | $ | ||
TOTAL LIABILITIES | $ | $ | ||
STOCKHOLDERS’ EQUITY | ||||
Class A common stock ($ outstanding at March 31, 2026 and December 31, 2025, respectively) | ||||
Class B common stock ($ March 31, 2026; | ||||
Preferred stock ($ December 31, 2025) | ||||
Additional paid-in capital | ||||
Retained earnings | ||||
Accumulated other comprehensive income | ||||
Total stockholders’ equity attributable to Ryan Specialty Holdings, Inc. | $ | $ | ||
Non-controlling interests | ||||
Total stockholders’ equity | $ | $ | ||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | $ |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||
Net income (loss) | $ | $( | ||
Adjustments to reconcile net income (loss) to cash flows provided by operating activities: | ||||
Income from equity method investments | ( | ( | ||
Amortization | ||||
Depreciation | ||||
Prepaid and deferred compensation expense | ||||
Non-cash equity-based compensation | ||||
Amortization of deferred debt issuance costs | ||||
Amortization of interest rate cap premium | ||||
Deferred income tax expense | ||||
Deferred income tax expense from common control reorganization | ||||
Changes in operating assets and liabilities, net of acquisitions: | ||||
Commissions and fees receivable – net | ( | ( | ||
Accrued interest liability | ( | ( | ||
Other current and non-current assets | ||||
Other current and non-current liabilities | ( | ( | ||
Total cash flows used in operating activities | $( | $( | ||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||
Business combinations – net of cash acquired and cash held in a fiduciary capacity | ( | |||
Capital expenditures | ( | ( | ||
Asset acquisitions | ( | |||
Total cash flows used in investing activities | $( | $( | ||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||
Borrowings on Revolving Credit Facility | ||||
Repayments on Revolving Credit Facility | ( | ( | ||
Debt issuance costs paid | ( | |||
Repayment of term debt | ( | ( | ||
Receipt of contingently returnable consideration | ||||
Payment of contingent consideration | ( | ( | ||
Tax distributions to non-controlling LLC Unitholders | ( | |||
Receipt of taxes related to net share settlement of equity awards | ||||
Taxes paid related to net share settlement of equity awards | ( | ( | ||
Class A common stock dividends and Dividend Equivalents paid | ( | ( | ||
Distributions and Declared Distributions paid to non-controlling LLC Unitholders | ( | ( | ||
Repurchases of Class A common stock | ( | |||
Payments related to Ryan Re preferred units | ( | |||
Net change in fiduciary liabilities | ( | ( | ||
Total cash flows provided by financing activities | $ | $ | ||
Effect of changes in foreign exchange rates on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | ( | |||
NET CHANGE IN CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY | $( | $( | ||
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY —Beginning balance | ||||
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY —Ending balance | $ | $ | ||
Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | ||||
Cash and cash equivalents | $ | $ | ||
Cash and cash equivalents held in a fiduciary capacity | ||||
Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | $ | $ | ||
Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income | Non- controlling Interests | Total Stockholders’ Equity | ||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||
Balance at December 31, 2025 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | — | — | — | — | — | — | ||||||||||
Exchange of LLC equity for common stock | — | ( | ( | — | — | ( | ||||||||||||
Cash and common stock clawbacks related to vested equity awards | ( | — | — | — | ( | — | — | ( | ||||||||||
Repurchase and retirement of common stock | ( | ( | — | — | ( | — | — | ( | ( | |||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non-controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | ( | ( | |||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investments’ other comprehensive income | — | — | — | — | — | — | ||||||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ( | ( | ( | |||||||||
Equity-based compensation | — | — | — | — | — | — | ( | |||||||||||
Balance at March 31, 2026 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Non- controlling Interests | Total Stockholders’ Equity | ||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||
Balance at December 31, 2024 | $ | $ | $ | $ | $( | $ | $ | |||||||||||
Net income (loss) | — | — | — | — | — | ( | — | ( | ||||||||||
Issuance of common stock | — | — | — | — | — | — | — | — | ||||||||||
Exchange of LLC equity for common stock | ( | — | — | — | ( | |||||||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non-controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | ( | ||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investment’s other comprehensive loss | — | — | — | — | — | — | ( | ( | ( | |||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ||||||||||||
Equity-based compensation | — | — | — | — | — | — | ( | |||||||||||
Balance at March 31, 2025 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Wholesale Brokerage | $ | $ | ||
Binding Authority | ||||
Underwriting Management | ||||
Total Net commissions and fees | $ | $ | ||
Three Months Ended March 31, 2025 | ||
Total revenue | $ | |
Net income |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Change in contingent consideration | $ | $( | ||
Interest expense, net | ||||
Total | $ | $( | ||
Three Months Ended March 31, 2026 | ||
Business platform optimization | $ | |
Compensation and benefits | ||
Total | $ |
Business Platform Optimization | Compensation and Benefits | Total | ||||
Balance at January 1, 2026 | $ | $ | $ | |||
Accrued costs | ||||||
Payments | ( | ( | ( | |||
Balance at March 31, 2026 | $ | $ | $ |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Balance at beginning of period | $ | $ | ||
Write-offs | ( | ( | ||
Increase in provision | ||||
Balance at end of period | $ | $ | ||
March 31, 2026 | December 31, 2025 | |||
Prepaid expenses | $ | $ | ||
Other current receivables | ||||
Total Other current assets | $ | $ |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Lease costs | ||||
Operating lease costs | $ | $ | ||
Short-term lease costs | ||||
Operating lease costs | ||||
Sublease income | ( | ( | ||
Lease costs – net | $ | $ | ||
Cash paid for amounts included in the measurement of lease liabilities | ||||
Operating cash flows used for operating leases | $ | $ | ||
Non-cash related activities | ||||
Right-of-use assets obtained in exchange for new operating lease liabilities | ||||
Amortization of right-of-use assets for operating leases | ||||
Weighted-average discount rate (percent) | ||||
Operating leases | ||||
Weighted-average remaining lease term (years) | ||||
Operating leases | ||||
March 31, 2026 | December 31, 2025 | |||
Term debt | ||||
payments, Adjusted Term SOFR + | $ | $ | ||
Senior secured notes | ||||
mature February 1, 2030 | ||||
mature August 1, 2032 | ||||
Revolving debt | ||||
SOFR + up to July 30, 2029 | ||||
Premium financing notes | ||||
Commercial notes, periodic interest and principal payments, expire May 1, 2026 | ||||
Commercial notes, periodic interest and principal payments, expire June 1, 2026 | ||||
Commercial notes, periodic interest and principal payments, expire June 21, 2026 | ||||
Total debt | $ | $ | ||
Less: Short-term debt and current portion of long-term debt | ( | ( | ||
Long-term debt | $ | $ |
Three Months Ended March 31, 2026 | |||||||||
IPO RSUs | Incentive RSUs | ||||||||
Restricted Stock Units | Weighted Average Grant Date Fair Value | Restricted Stock Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | ( | ( | |||||||
Forfeited | ( | ( | |||||||
Unvested at end of period | $ | $ | |||||||
Three Months Ended March 31, 2026 | |||||||||
Reload Options1 | Staking Options1 | Incentive Options | Incentive Options Weighted Average Exercise Price | ||||||
Outstanding at beginning of period | $ | ||||||||
Granted | |||||||||
Exercised | ( | ( | |||||||
Forfeited or expired | ( | ||||||||
Outstanding at end of period | $ | ||||||||
Aggregate intrinsic value ($ in thousands): | ||
Reload Options outstanding | $ | |
Reload Options exercisable | ||
Staking Options outstanding | ||
Staking Options exercisable | ||
Incentive Options outstanding | ||
Incentive Options exercisable | ||
Weighted-average remaining contractual term (in years): | ||
Reload Options outstanding | ||
Reload Options exercisable | ||
Staking Options outstanding | ||
Staking Options exercisable | ||
Incentive Options outstanding | ||
Incentive Options exercisable |
Three Months Ended March 31, 2026 | |||||||||
IPO RLUs | Incentive RLUs | ||||||||
Restricted LLC Units | Weighted Average Grant Date Fair Value | Restricted LLC Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | |||||||||
Forfeited | |||||||||
Unvested at end of period | $ | $ | |||||||
Three Months Ended March 31, 2026 | |||||||||
Reload Class C Incentive Units | Staking Class C Incentive Units | Class C Incentive Units | Class C Incentive Units Weighted Average Participation Threshold | ||||||
Unvested at beginning of period | $ | ||||||||
Granted | |||||||||
Vested | |||||||||
Forfeited | |||||||||
Unvested at end of period | $ | ||||||||
Three Months Ended March 31, 2026 | |||||||||
PSUs | PLUs | ||||||||
Performance Stock Units | Weighted Average Grant Date Fair Value | Performance LLC Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | |||||||||
Forfeited | ( | ||||||||
Unvested at end of period | $ | $ | |||||||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
IPO awards | ||||
IPO RSUs and Staking Options | $ | $ | ||
IPO RLUs and Staking Class C Incentive Units | ||||
Incremental Restricted Stock and Reload Options | ||||
Incremental Restricted Common Units and Reload Class C Incentive Units | ||||
Pre-IPO incentive awards | ||||
Restricted Stock | ||||
Restricted Common Units | ||||
Post-IPO incentive awards | ||||
Incentive RSUs | ||||
Incentive RLUs | ||||
Incentive Options | ||||
Class C Incentive Units | ||||
PSUs | ||||
PLUs | ||||
Other expense | ||||
Director Stock Grants | ||||
Total equity-based compensation expense | $ | $ | ||
Amount | Weighted Average Remaining Expense Period (Years) | |||
IPO RSUs | $ | |||
Incentive RSUs | ||||
Reload Options | ||||
Incentive Options | ||||
PSUs | ||||
IPO RLUs | ||||
Incentive RLUs | ||||
Reload Class C Incentive Units | ||||
Staking Class C Incentive Units | ||||
Class C Incentive Units | ||||
Total unrecognized equity-based compensation expense | $ |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Net income (loss) | $ | $( | ||
Less: Net income attributable to non-controlling interests | ||||
Net income (loss) attributable to Ryan Specialty Holdings, Inc. | $ | $( | ||
Numerator: | ||||
Net income (loss) attributable to Class A common shareholders – basic | $ | $( | ||
Less: Loss attributed to dilutive shares | ( | |||
Net income (loss) attributable to Class A common shareholders – diluted | $ | $( | ||
Denominator: | ||||
Weighted-average shares of Class A common stock outstanding – basic | ||||
Add: Dilutive shares | ||||
Weighted-average shares of Class A common stock outstanding – diluted | ||||
Earnings (loss) per share | ||||
Earnings (loss) per share of Class A common stock – basic | $ | $( | ||
Earnings (loss) per share of Class A common stock – diluted | $ | $( | ||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Conversion of non-controlling interest LLC Common Units1 | ||||
Restricted Stock | ||||
IPO RSUs | ||||
Incentive RSUs | ||||
PSUs | ||||
Reload Options | ||||
Staking Options | ||||
Incentive Options | ||||
Restricted Common Units | ||||
IPO RLUs | ||||
Incentive RLUs | ||||
PLUs | ||||
Reload Class C Incentive Units | ||||
Staking Class C Incentive Units | ||||
Class C Incentive Units | ||||
Income Statement Caption | Three Months Ended March 31, 2025 | ||
Interest rate cap premium amortization | Interest expense, net | $( | |
Amounts reclassified out of other comprehensive income related to the interest rate cap | Interest expense, net | ||
Total impact of derivatives designated as hedging instruments | $ | ||
March 31, 2026 | December 31, 2025 | |||||||||||
Level 1 | Level 2 | Level 3 | Level 1 | Level 2 | Level 3 | |||||||
Assets | ||||||||||||
Contingently returnable consideration | $ | $ | $ | $ | $ | $ | ||||||
Liabilities | ||||||||||||
Contingent consideration | ||||||||||||
Total assets and liabilities measured at fair value | $ | $ | $ | $ | $ | $ | ||||||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Assets | ||||
Balance at beginning of period | $ | $ | ||
Total gains included in earnings | ||||
Foreign currency translation adjustments included in OCI | ( | |||
Settlements | ( | ( | ||
Balance at end of period | $ | $ | ||
Liabilities | ||||
Balance at beginning of period | $ | $ | ||
Newly established liabilities due to acquisitions | ||||
Total (gains) losses included in earnings | ( | |||
Foreign currency translation adjustments included in OCI | ( | |||
Settlements | ( | ( | ||
Balance at end of period | $ | $ | ||
Exchange Tax Attributes | Pre-IPO M&A Tax Attributes | TRA Payment Tax Attributes | TRA Liabilities | |||||
Balance at December 31, 2025 | $ | $ | $ | $ | ||||
Exchange of LLC Common Units | ||||||||
Balance at March 31, 2026 | $ | $ | $ | $ |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Gain on interest rate cap | $ | $( | ||
Gain on interest rate cap reclassified to earnings | ||||
Foreign currency translation adjustments | ( | |||
Change in share of equity method investments’ other comprehensive income (loss) | ( | |||
Foreign Currency Translation Adjustments | Change in EMI Other Comprehensive Income (Loss)1 | Total | ||||
Balance at December 31, 2025 | $ | $ | $ | |||
Other comprehensive income (loss) before reclassifications | ( | ( | ||||
Amounts reclassified to earnings | ||||||
Other comprehensive income (loss) | $( | $ | $( | |||
Less: Non-controlling interests | ( | ( | ||||
Balance at March 31, 2026 | $ | $ | $ |
Gain on Interest Rate Cap | Foreign Currency Translation Adjustments | Change in EMI Other Comprehensive Income (Loss)1 | Total | |||||
Balance at December 31, 2024 | $ | $( | $( | $( | ||||
Other comprehensive income (loss) before reclassifications | (3,419) | ( | ||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $ | $( | $ | ||||
Less: Non-controlling interests | ( | ( | ||||||
Balance at March 31, 2025 | $ | $ | $( | $ |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Net commissions and fees | $ | $ | ||
Fiduciary investment income | ||||
Total revenue | $ | $ | ||
Compensation-related expense1 | ||||
General and administrative expense2 | ||||
Other segment items3 | ||||
Depreciation and amortization | ||||
Change in contingent consideration | ( | |||
Interest income | ( | ( | ||
Interest expense | ||||
Income from equity method investments | ( | ( | ||
Other non-operating income | ( | ( | ||
Income tax expense | ||||
Net income (loss) | $ | $( | ||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
United States | $ | $ | ||
Foreign | ||||
Total revenue | $ | $ | ||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Cash paid (received) for: | ||||
Interest, net1 | $ | $ | ||
Income taxes, net of refunds | ( | |||
Non-cash investing and financing activities: | ||||
Non-controlling interest holders’ tax distributions declared but unpaid | $ | $ | ||
Tax Receivable Agreement liabilities | ||||
Excise tax payable on net share repurchases | ||||
Dividend Equivalents and Declared Distributions liabilities | ||||
Contingent consideration liabilities | ||||
Three Months Ended March 31, | Change | ||||||
(in thousands, except percentages and per share data) | 2026 | 2025 | $ | % | |||
Revenue | |||||||
Net commissions and fees | $782,903 | $676,128 | $106,775 | 15.8 % | |||
Fiduciary investment income | 12,326 | 14,038 | (1,712) | (12.2) | |||
Total revenue | $795,229 | $690,166 | $105,063 | 15.2 % | |||
Expenses | |||||||
Compensation and benefits | 495,176 | 430,289 | 64,887 | 15.1 | |||
General and administrative | 108,761 | 106,060 | 2,701 | 2.5 | |||
Amortization | 65,340 | 64,985 | 355 | 0.5 | |||
Depreciation | 4,062 | 2,639 | 1,423 | 53.9 | |||
Change in contingent consideration | 27,294 | (14,042) | 41,336 | NM | |||
Total operating expenses | $700,633 | $589,931 | $110,702 | 18.8 % | |||
Operating income | $94,596 | $100,235 | $(5,639) | (5.6 %) | |||
Interest expense, net | 53,733 | 54,508 | (775) | (1.4) | |||
Income from equity method investments | (5,531) | (4,937) | (594) | 12.0 | |||
Other non-operating income | (711) | (377) | (334) | 88.6 | |||
Income before income taxes | $47,105 | $51,041 | $(3,936) | (7.7 %) | |||
Income tax expense | 6,508 | 55,430 | (48,922) | (88.3) | |||
Net income (loss) | $40,597 | $(4,389) | $44,986 | NM | |||
GAAP financial measures | |||||||
Total revenue | $795,229 | $690,166 | $105,063 | 15.2 % | |||
Net commissions and fees | 782,903 | 676,128 | 106,775 | 15.8 | |||
Compensation and benefits | 495,176 | 430,289 | 64,887 | 15.1 | |||
General and administrative | 108,761 | 106,060 | 2,701 | 2.5 | |||
Net income (loss) | 40,597 | (4,389) | 44,986 | NM | |||
Compensation and benefits expense ratio (1) | 62.3 % | 62.3 % | |||||
General and administrative expense ratio (2) | 13.7 % | 15.4 % | |||||
Net income (loss) margin (3) | 5.1 % | (0.6 %) | |||||
Earnings (loss) per share (4) | $0.14 | $(0.22) | |||||
Diluted earnings (loss) per share (4) | $0.13 | $(0.22) | |||||
Non-GAAP financial measures* | |||||||
Organic revenue growth rate | 11.8 % | 12.9 % | |||||
Adjusted compensation and benefits expense | $461,832 | $397,428 | $64,404 | 16.2% | |||
Adjusted compensation and benefits expense ratio | 58.1 % | 57.6 % | |||||
Adjusted general and administrative expense | $101,365 | $92,237 | $9,128 | 9.9% | |||
Adjusted general and administrative expense ratio | 12.7 % | 13.4 % | |||||
Adjusted EBITDAC | $232,033 | $200,501 | $31,532 | 15.7% | |||
Adjusted EBITDAC margin | 29.2 % | 29.1 % | |||||
Adjusted net income | $130,728 | $107,839 | $22,889 | 21.2% | |||
Adjusted net income margin | 16.4 % | 15.6 % | |||||
Adjusted diluted earnings per share | $0.47 | $0.39 | $0.08 | 20.5% | |||
Three Months Ended March 31, | ||||||||||||
(in thousands, except percentages) | 2026 | % of total | 2025 | % of total | Change | |||||||
Wholesale Brokerage | $377,796 | 48.3 % | $360,788 | 53.4 % | $17,008 | 4.7 % | ||||||
Binding Authority | 110,000 | 14.0 | 101,950 | 15.1 | 8,050 | 7.9 | ||||||
Underwriting Management | 295,107 | 37.7 | 213,390 | 31.5 | 81,717 | 38.3 | ||||||
Total Net commissions and fees | $782,903 | $676,128 | $106,775 | 15.8 % | ||||||||
Three Months Ended March 31, | ||||||||||||
(in thousands, except percentages) | 2026 | % of total | 2025 | % of total | Change | |||||||
Net commissions and policy fees | $717,553 | 91.7 % | $623,966 | 92.3 % | $93,587 | 15.0 % | ||||||
Supplemental and contingent commissions | 49,117 | 6.3 | 37,773 | 5.6 | 11,344 | 30.0 | ||||||
Loss mitigation and other fees | 16,233 | 2.0 | 14,389 | 2.1 | 1,844 | 12.8 | ||||||
Total Net commissions and fees | $782,903 | $676,128 | $106,775 | 15.8 % | ||||||||
Three Months Ended March 31, | ||||
(in thousands, except percentages) | 2026 | 2025 | ||
Current period Net commissions and fees revenue | $782,903 | $676,128 | ||
Less: Current period contingent commissions | (42,373) | (30,463) | ||
Less: Revenue attributable to sold businesses | (13) | (146) | ||
Net commissions and fees revenue excluding contingent commissions | $740,517 | $645,519 | ||
Prior period Net commissions and fees revenue | $676,128 | $537,887 | ||
Less: Prior year contingent commissions | (30,463) | (24,503) | ||
Less: Revenue attributable to sold businesses | (657) | (539) | ||
Prior period Net commissions and fees revenue excluding contingent commissions | $645,008 | $512,845 | ||
Change in Net commissions and fees revenue excluding contingent commissions | $95,509 | $132,674 | ||
Less: Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions | (15,246) | (67,155) | ||
Impact of change in foreign exchange rates | (3,863) | 430 | ||
Organic revenue growth (Non-GAAP) | $76,400 | $65,949 | ||
Net commissions and fees revenue growth rate (GAAP) | 15.8 % | 25.7 % | ||
Less: Impact of contingent commissions (1) | (1.0) | 0.2 | ||
Net commissions and fees revenue excluding contingent commissions growth rate (2) | 14.8 % | 25.9 % | ||
Less: Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions (3) | (2.4) | (13.1) | ||
Impact of change in foreign exchange rates (4) | (0.6) | 0.1 | ||
Organic Revenue Growth Rate (Non-GAAP) | 11.8 % | 12.9 % | ||
Three Months Ended March 31, | ||||
(in thousands, except percentages) | 2026 | 2025 | ||
Total revenue | $795,229 | $690,166 | ||
Compensation and benefits expense | $495,176 | $430,289 | ||
Acquisition-related expense | (3,411) | (3,479) | ||
Acquisition related long-term incentive compensation | (9,287) | (8,331) | ||
Restructuring and related expense | (2,465) | — | ||
Amortization and expense related to discontinued prepaid incentives | (830) | (1,178) | ||
Equity-based compensation | (14,309) | (14,569) | ||
Initial public offering related expense | (3,042) | (5,304) | ||
Adjusted compensation and benefits expense (1) | $461,832 | $397,428 | ||
Compensation and benefits expense ratio | 62.3 % | 62.3 % | ||
Adjusted compensation and benefits expense ratio | 58.1 % | 57.6 % | ||
Three Months Ended March 31, | ||||
(in thousands, except percentages) | 2026 | 2025 | ||
Total revenue | $795,229 | $690,166 | ||
General and administrative expense | $108,761 | $106,060 | ||
Acquisition-related expense | (3,990) | (13,823) | ||
Restructuring and related expense | (3,406) | — | ||
Adjusted general and administrative expense (1) | $101,365 | $92,237 | ||
General and administrative expense ratio | 13.7 % | 15.4 % | ||
Adjusted general and administrative expense ratio | 12.7 % | 13.4 % | ||
Three Months Ended March 31, | ||||
(in thousands, except percentages) | 2026 | 2025 | ||
Total revenue | $795,229 | $690,166 | ||
Net income (loss) | $40,597 | $(4,389) | ||
Interest expense, net | 53,733 | 54,508 | ||
Income tax expense | 6,508 | 55,430 | ||
Depreciation | 4,062 | 2,639 | ||
Amortization | 65,340 | 64,985 | ||
Change in contingent consideration (1) | 27,294 | (14,042) | ||
EBITDAC | $197,534 | $159,131 | ||
Acquisition-related expense | 7,402 | 17,302 | ||
Acquisition related long-term incentive compensation | 9,287 | 8,331 | ||
Restructuring and related expense | 5,871 | — | ||
Amortization and expense related to discontinued prepaid incentives | 830 | 1,178 | ||
Other non-operating income | (711) | (377) | ||
Equity-based compensation | 14,309 | 14,569 | ||
IPO related expenses | 3,042 | 5,304 | ||
Income from equity method investments | (5,531) | (4,937) | ||
Adjusted EBITDAC | $232,033 | $200,501 | ||
Net income (loss) margin | 5.1 % | (0.6 %) | ||
Adjusted EBITDAC margin | 29.2 % | 29.1 % | ||
Three Months Ended March 31, | ||||
(in thousands, except percentages) | 2026 | 2025 | ||
Total revenue | $795,229 | $690,166 | ||
Net income (loss) | $40,597 | $(4,389) | ||
Income tax expense | 6,508 | 55,430 | ||
Amortization | 65,340 | 64,985 | ||
Amortization of deferred debt issuance costs (1) | 2,422 | 2,374 | ||
Change in contingent consideration | 27,294 | (14,042) | ||
Acquisition-related expense | 7,402 | 17,302 | ||
Acquisition related long-term incentive compensation | 9,287 | 8,331 | ||
Restructuring and related expense | 5,871 | — | ||
Amortization and expense related to discontinued prepaid incentives | 830 | 1,178 | ||
Other non-operating income | (711) | (377) | ||
Equity-based compensation | 14,309 | 14,569 | ||
IPO related expenses | 3,042 | 5,304 | ||
Income from equity method investments | (5,531) | (4,937) | ||
Adjusted income before income taxes (2) | $176,660 | $145,728 | ||
Adjusted income tax expense (3) | (45,932) | (37,889) | ||
Adjusted net income | $130,728 | $107,839 | ||
Net income (loss) margin | 5.1 % | (0.6 %) | ||
Adjusted net income margin | 16.4 % | 15.6 % | ||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Earnings (loss) per share of Class A common stock – diluted | $0.13 | $(0.22) | ||
Less: Net income attributed to dilutive shares (1) | — | — | ||
Plus: Impact of all LLC Common Units exchanged for Class A shares (2) | 0.02 | 0.20 | ||
Plus: Adjustments to Adjusted net income (3) | 0.33 | 0.43 | ||
Plus: Dilutive impact of unvested equity awards (4) | (0.01) | (0.02) | ||
Adjusted diluted earnings per share | $0.47 | $0.39 | ||
(Share count in ’000) | ||||
Weighted-average shares of Class A common stock outstanding – diluted | 137,341 | 125,420 | ||
Plus: Impact of all LLC Common Units exchanged for Class A shares (2) | 134,476 | 136,064 | ||
Plus: Dilutive impact of unvested equity awards (4) | 6,824 | 17,783 | ||
Adjusted diluted earnings per share diluted share count | 278,641 | 279,267 | ||
(in thousands) | Exchange Tax Attributes | Pre-IPO M&A Tax Attributes | TRA Payment Tax Attributes | TRA Liabilities | ||||
Balance at December 31, 2025 | $271,979 | $77,349 | $109,669 | $458,997 | ||||
Exchange of LLC Common Units | 1,146 | 116 | 585 | 1,847 | ||||
Accrued interest | — | — | — | — | ||||
Balance at March 31, 2026 | $273,125 | $77,465 | $110,254 | $460,844 |
Long-term Incentive Compensation Agreements | ||
(in thousands) | March 31, 2026 | |
Current accrued compensation | $8,054 | |
Non-current accrued compensation | 23,252 | |
Total liability | $31,306 | |
Projected future expense | 39,580 | |
Total projected future cash outflows | $70,886 | |
Projected Future Cash Outflows | ||
(in thousands) | ||
2026 | $10,794 | |
2027 | 8,983 | |
2028 | 32,616 | |
2029 | 10,884 | |
Thereafter | $7,609 | |
Contingent Consideration | ||
(in thousands) | March 31, 2026 | |
Current accounts payable and accrued liabilities | $86,625 | |
Other non-current liabilities | 91,213 | |
Total liability | $177,838 | |
Projected future expense | 8,477 | |
Total projected future cash outflows | $186,315 | |
Projected Future Cash Outflows | ||
(in thousands) | ||
2026 | $87,235 | |
2027 | 91,091 | |
2028 | 4,926 | |
2029 | 2,896 | |
Thereafter | $167 | |
(in thousands) | Balance at March 31, 2026 | 100 BPS Increase | 100 BPS Decrease | |||
Cash and cash equivalents | $154,650 | $(1,547) | $1,547 | |||
Term Loan principal outstanding (1) | 1,678,800 | 16,788 | (16,788) | |||
Net exposure to Interest expense, net | $15,242 | $(15,242) | ||||
Cash and cash equivalents held in a fiduciary capacity | $1,330,238 | $13,302 | $(13,302) | |||
Net exposure to Fiduciary investment income | $13,302 | $(13,302) | ||||
Impact to Net income (loss) | $(1,939) | $1,939 |
Period | Total Number of Shares Purchased | Average Price Paid per Share 1 | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs 2 | ||||
1/1/26 - 1/31/26 | — | $— | — | $— | ||||
2/1/26 - 2/28/26 | 982,073 | 40.7301 | 982,073 | 260,000,036 | ||||
3/1/26 - 3/31/26 | — | — | — | 260,000,036 | ||||
TOTAL | 982,073 | $40.7301 | $40.7301 | 982,073 |
Exhibit Number | Description | |
3.1 | Amended and Restated Certificate of Incorporation of Ryan Specialty Holdings, Inc., dated May 30, 2025 (incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K filed on June 4, 2025). | |
3.2 | Amended and Restated Bylaws of Ryan Specialty Holdings, Inc., dated May 30, 2025 (incorporated by reference to Exhibit 3.2 to the Registrant’s Form 8-K filed on June 4, 2025). | |
4.1 | Registration Rights Agreement, dated July 26, 2021, by and among Ryan Specialty Holdings, Inc. and the other signatories party thereto (incorporated by reference to Exhibit 4.1 to the Registrant’s Form 8-K filed on July 27, 2021). | |
4.2 | Indenture, dated as of February 3, 2022, by and among Ryan Specialty, LLC, the guarantors party thereto and U.S. Bank National Association as trustee and as notes collateral agent (incorporated by reference to Exhibit 4.1 to the Registrant’s Form 8-K filed on February 7, 2022). | |
4.3 | Form of 4.375% Senior Secured Notes due 2030 (incorporated by reference to Exhibit A to Exhibit 4.1 to the Registrant’s Form 8-K filed on February 7, 2022). | |
4.4 | Indenture, dated as of September 19, 2024, by and among Ryan Specialty, LLC, the guarantors party thereto and U.S. Bank National Association as trustee and as notes collateral agent (incorporated by reference to Exhibit 4.1 to the Registrant’s Form 8-K filed on September 19, 2024). | |
4.5 | Form of 5.875% Senior Secured Notes due 2032 (incorporated by reference to Exhibit A to Exhibit 4.1 to the Registrant’s Form 8-K filed on September 19, 2024). | |
4.6 | First Supplemental Indenture to that certain Indenture, dated as of September 19, 2024, by and among Ryan Specialty, LLC, the guarantors party thereto and U.S. Bank National Association as trustee and as notes collateral agent (incorporated by reference to Exhibit 4.2 to the Registrant’s Form 8-K filed on December 9, 2024) | |
10.1 | Amended and Restated Tax Receivable Agreement, dated as of August 9, 2022, by and among Ryan Specialty Holdings, Inc. and the other signatories party thereto (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed on August 12, 2022). | |
10.2 | Eighth Amended and Restated Limited Liability Company Agreement of Ryan Specialty, LLC, dated as of July 5, 2023, by and among Ryan Specialty, LLC and the other signatories party thereto, (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q filed on November 03, 2023). | |
10.3 | Form of Director and Officer Indemnification Agreement, by and among Ryan Specialty Holdings, Inc. and the other signatories party thereto (incorporated by reference to Exhibit 10.4 to the Registrant’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on June 21, 2021). | |
10.4 | Indemnification Agreement, by and among Ryan Specialty Holdings, Inc. and Patrick G. Ryan, dated as of July 26, 2021 (incorporated by reference to Exhibit 10.4 to the Registrant’s Form 8-K filed on July 27, 2021). | |
10.5 | Director Nomination Agreement, dated as of July 26, 2021, by and among Ryan Specialty Holdings, Inc. and the other signatories party thereto (incorporated by reference to Exhibit 10.5 to the Registrant’s Form 8- K filed on July 27, 2021). | |
10.6 | Ryan Specialty Holdings, Inc. 2021 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.7 to the Registrant’s Quarterly Report on Form 10-Q filed on August 12, 2022). | |
10.7 | First Amendment to the Ryan Specialty Holdings, Inc. 2021 Omnibus Incentive Plan, (incorporated by reference to Exhibit 10.8 to the Registrant’s Form 10-K filed on March 1, 2023). | |
10.8 | Ryan Specialty Holdings, Inc. Form of Class C Common Incentive Unit Grant Agreement (Staking Unit) (incorporated by reference to Exhibit 10.6 to the Registrant’s Registration Statement on Form S-8 filed on July 23, 2021). | |
10.9 | Ryan Specialty Holdings, Inc. Form of Class C Common Incentive Unit Grant Agreement (Reload Unit) (incorporated by reference to Exhibit 10.7 to the Registrant’s Registration Statement on Form S-8 filed on July 23, 2021). |
10.10 | Ryan Specialty Holdings, Inc. Form of Common Unit Grant Agreement (incorporated by reference to Exhibit 10.8 to the Registrant’s Registration Statement on Form S-8 filed on July 23, 2021). | |
10.11 | Ryan Specialty Holdings, Inc. Form of Restricted Stock Unit Agreement (Non-Employee Directors) (incorporated by reference to Exhibit 10.15 to the Registrant’s Form 10-K filed on March 16, 2022). | |
10.12 | Ryan Specialty Holdings, Inc. Form of Restricted LLC Unit Agreement (2022), (incorporated by reference to Exhibit 10.11 to the Registrant’s Form 10-K filed on February 28, 2024). | |
10.13 | Ryan Specialty Holdings, Inc. Form of Class C Common Incentive Unit Grant Agreement (PSI Units), (incorporated by reference to Exhibit 10.12 to the Registrant’s Form 10-K filed on February 28, 2024). | |
10.14 | Ryan Specialty Holdings, Inc. Form of Performance-Based Restricted Stock Unit Agreement (DELTA PSUs), (incorporated by reference to Exhibit 10.14 to the Registrant’s Form 10-Q filed on May 30, 2024). | |
10.15 | Ryan Specialty Holdings, Inc. Form of Performance-Based Restricted LLC Unit Agreement (DELTA PLUs), (incorporated by reference to Exhibit 10.15 to the Registrant’s Form 10-K filed on February 28, 2024). | |
10.17 | Seventh Amendment to the Credit Agreement, dated September 13, 2024, including Exhibit A, a conformed copy of the Credit Agreement, dated as of September 1, 2020, among Ryan Specialty, LLC and JPMorgan Chase Bank, N.A., as administrative agent and the other lenders party thereto, as amended March 30, 2021, July 26, 2021, August 13, 2021, April 29, 2022, January 19, 2024, July 30, 2024 and September 13, 2024, (incorporated by reference to Exhibit 10.16 to the Registrant’s Form 10-Q filed on October 31, 2024). | |
10.18 | Third Amended and Restated Limited Liability Company Operating Agreement of New Ryan Specialty, LLC, dated as of July 5, 2023, by and among New Ryan Specialty, LLC and the other signatories party thereto, (incorporated by reference to Exhibit 10.20 to the Registrant’s Quarterly Report on Form 10-Q filed on November 03, 2023). | |
10.19 | First Amendment to the Third Amended and Restated Limited Liability Company Operating Agreement of New Ryan Specialty, LLC, dated as of April 30, 2024, by and among New Ryan Specialty, LLC and the other signatories party thereto, (incorporated by reference to Exhibit 10.18 to the Registrant’s Quarterly Report on Form 10-Q filed on August 02, 2024). | |
10.20 | Ryan Specialty Group Services, LLC Executive Severance Plan, (incorporated by reference to Exhibit 10.15 to the Registrant’s Form 10-K filed on February 28, 2024). | |
19.1 | Ryan Specialty Holdings, Inc. Insider Trading Policy dated May 1, 2023, (incorporated by reference to Exhibit 19.1 to the Registrant’s Form 10-K filed on February 21, 2025). | |
31.1 | Certification of the Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith. | |
31.2 | Certification of the Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith. | |
32.1* | Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, filed herewith. | |
32.2* | Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, filed herewith. | |
97.1 | Clawback Policy Pursuant to Rule 10D-1 under the Exchange Act, (incorporated by reference to Exhibit 97.1 to the Registrant’s Form 10-K filed on February 28, 2024). | |
101.INS | Inline XBRL (Extensible Business Reporting Language) Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |
101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | |
104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
RYAN SPECIALTY HOLDINGS, INC. (Registrant) | ||
Date: May 1, 2026 | By: | /s/ Janice M. Hamilton |
Janice M. Hamilton | ||
Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | ||